CoChat
Sign Up
Cited by 767Gestational Diabetes Research and ManagementDiabetes Management and ResearchPregnancy and Medication Impact

The International Federation of Gynecology and Obstetrics (FIGO) Initiative on gestational diabetes mellitus: A pragmatic guide for diagnosis, management, and care #

Open access
Hod, Moshe, Kapur, Anil, Sacks, David A., Hadar, Eran, Agarwal, Mukesh, Di Renzo, Gian Carlo, Roura, Luis Cabero, McIntyre, Harold David +2 more·2015·International Journal of Gynecology & Obstetrics
DOI 10.1016/s0020-7292(15)30033-3
Open this paper in CoChat — free accountOpen PDF

Abstract

The following external groups evaluated the document and support its contents: European Board and College of Obstetrics and Gynaecology (EBCOG), The Society of Obstetricians and Gynaecologists of Canada (SOGC), Chinese Society of Perinatal Medicine, Diabetic Pregnancy Study Group (DPSG), African Federation of Obstetrics and Gynaecology (AFOG), South Asian Federation of Obstetrics and Gynecology (SAFOG), Australian Diabetes in Pregnancy Society (ADIPS), International Association of Diabetes in Pregnancy Study Groups (IADPSG), European Association of Perinatal Medicine (EAPM), Diabetes in Pregnancy Study Group of India (DIPSI), and the Diabetes in Pregnancy Study Group of Latin America.In addition to the FIGO Executive Board, all relevant FIGO Committees and Working Groups contributed to and supported the document.Women queue for gestational diabetes services in Barranquilla, Colombia.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0020-7292(15)30033-3

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Universal screening for gestational diabetes is recommended because selective screening would miss many cases and universal screening is cost-effective.

    “Universal screening is recommended, as selective screening (only in women with risk factors) would miss a significant number of women with GDM and universal screening has been shown to be cost-effective compared with selective screening.”

    From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [54]

    Section 5.2 recommends universal testing because risk-factor-based selective testing has poor sensitivity for detecting GDM. But section 5.4 says there is a lack of good evidence for the cost-effectiveness of universal testing in both high- and low-resource countries; it does not establish that universal screening is cost-effective compared with selective screening. (LLM, conf=0.90)

    Experimental — accuracy not yet measured

  • Universal screening for gestational diabetes is cost-effective compared with selective screening.

    “Universal screening is recommended, as selective screening (only in women with risk factors) would miss a significant number of women with GDM and universal screening has been shown to be cost-effective compared with selective screening.9,50–55”

    From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [54]

    Section 5.2 recommends universal rather than risk-factor-based testing because selective testing has poor sensitivity. The Cost-effectiveness studies section says models suggest GDM testing and care are cost-effective, but does not establish that universal testing is cost-effective compared with selective testing. Section 5.4 explicitly notes a lack of good evidence for the cost-effectiveness of universal testing. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

  • Selective screening based only on risk factors would miss a significant number of women with gestational diabetes.

    “Universal screening is recommended, as selective screening (only in women with risk factors) would miss a significant number of women with GDM and universal screening has been shown to be cost-effective compared with selective screening.9,50–55”

    From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [54]

  • The International Association for Diabetes and Pregnancy Study Groups criteria lead to higher percentages of women diagnosed with gestational diabetes.

    “The International Association for Diabetes and Pregnancy Study Groups criteria result in overall higher percentages of women diagnosed with GDM.”

    From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [54]

    Section 5.1 describes the IADPSG diagnostic thresholds, and Section 4.5 says GDM prevalence varies with the criteria used. Neither reports that IADPSG criteria diagnose a higher overall percentage of women than other criteria. Searches for increased prevalence and comparative diagnosis rates found no passage establishing that direction. (LLM, conf=0.72)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 214

  1. International Association of Diabetes and Pregnancy Study Groups Consensus Panel, Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010;33(3):676-82.
  2. McIntyre HD, Metzger BE, Coustan DR, Dyer AR, Hadden DR, Hod M, et al. Counterpoint: Establishing consensus in the diagnosis of GDM following the HAPO study. Curr Diab Rep 2014;14(6):497.
  3. Proceedings of the 4th International Workshop-Conference on Gestational Diabetes Mellitus. Chicago, Illinois, USA. 14-16 March 1997. Diabetes Care 1998;21(Suppl. 2):B1-B167.
  4. Greene MF. Screening for gestational diabetes mellitus. N Engl J Med 1997;337(22):1625-6.
  5. Mendez MA, Monteiro CA, Popkin BM. Overweight exceeds under- weight among women in most developing countries. Am J Clin Nutr 2005;81(3):714-21.
  6. Matyka KA. Type 2 diabetes in childhood: epidemiological and clinical aspects. Br Med Bull 2008;86:59-75.
  7. Jiwani A, Marseille E, Lohse N, Damm P, Hod M, Kahn JG. Gestational diabetes mellitus: results from a survey of country prevalence and practices. J Matern Fetal Neonatal Med 2012;25(6):600-10.
  8. Berger H, Crane J, Farine D, Armson A, De La Ronde S, Keenan-Lindsay L, et al. Screening for gestational diabetes mellitus. J Obstet Gynaecol Can 2002;24(11):894-912.
  9. Lavin JP Jr. Screening of high-risk and general populations for gestational dia- betes. Clinical application and cost analysis. Diabetes 1985;34: S24-S27.
  10. Coustan DR, Nelson C, Carpenter MW, Carr SR, Rotondo L, Widness JA. Maternal age and screening for gestational diabetes: a population-based study. Obstet Gynecol 1989;73(4):557-61.
  11. Moses RG, Moses J, Davis WS. Gestational diabetes: do lean young caucasian women need to be tested? Diabetes Care 1998;21(11):1803-6.
  12. Neilsen KK, De Courten M, Kapur A. The urgent need for universally appli- cable simple screening procedures and diagnostic criteria for gestational diabetes mellitus -lessons from projects funded by the World Diabetes Foundation. Glob Health Action 2012;5: 17277.
  13. Rudge MV, Calderon IM, Ramos MD, Peraçoli JC, Pim A. Hypertensive dis- orders in pregnant women with diabetes mellitus. Gynecol Obstet Invest 1997;44(1):11-5.
  14. Ehrenberg HM, Durnwald CP, Catalano P, Mercer BM. The influence of obes- ity and diabetes on the risk of cesarean delivery. Am J Obstet Gynecol. 2004;191(3):969-74.
  15. Peters RK, Kjos SL, Xiang A, Buchanan TA. Long-term diabetogenic effect of single pregnancy in women with previous gestational diabetes mellitus. Lancet 1996;347(8996):227-30.
  16. Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 2002;25(10):1862-8.
  17. Langer O, Rodriguez DA, Xenakis EM, McFarland MB, Berkus MD, Arrendondo F. Intensified versus conventional management of gestational diabetes. Am J Obstet Gynecol 1994;170(4):1036-46; discussion 1046-7.
  18. Modanlou HD, Komatsu G, Dorchester W, Freeman RK, Bosu SK. Large-for-gestational-age neonates: anthropometric reasons for shoulder dystocia. Obstet Gynecol 1982;60(4):417-23.
  19. McFarland MB, Trylovich CG, Langer O. Anthropometric differences in mac- rosomic infants of diabetic and nondiabetic mothers. J Matern Fetal Med 1998;7(6):292-5.
  20. Pedersen J, Bojsen-Møller B, Poulsen H. Blood sugar in newborn infants of diabetic mothers. Acta Endocrinol (Copenh) 1954;15(1):33-52.
  21. Van Assche FA, Gepts W. The cytological composition of the foetal endo- crine pancreas in normal and pathological conditions. Diabetologia 1971;7(6):434-4.
  22. Aerts L, Van Assche FA. Is gestational diabetes an acquired condition? J Dev Physiol 1979;1(3):219-25.
  23. Freinkel N. Banting Lecture 1980. Of pregnancy and progeny. Diabetes 1980;29(12):1023-35.
  24. Bellamy L, Casas JP, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 2009;373(9677):1773-9.
  25. Ratner RE, Christophi CA, Metzger BE, Dabelea D, Bennett PH, Pi-Sunyer X, et al. Prevention of diabetes in women with a history of gestational diabe- tes: effects of metformin and lifestyle interventions. J Clin Endocrinol Metab 2008;93(12):4774-9.
  26. Retnakaran R. Glucose tolerance status in pregnancy: a window to the future risk of diabetes and cardiovascular disease in young women. Curr Diabetes Rev 2009;5(4):239-44.
  27. Retnakaran R, Shah BR. Mild glucose intolerance in pregnancy and risk of cardiovascular disease: a population-based cohort study. CMAJ 2009;181(6-7):371-6.
  28. Kessous R, Shoham-Vardi I, Pariente G, Sherf M, Sheiner E. An association between gestational diabetes mellitus and long-term maternal cardiovascu- lar morbidity. Heart 2013;99(15):1118-21. glucose tolerance test and adverse pregnancy outcomes. Diabetes Care 2001;24(7):1151-5.
  29. McIntyre HD, Colagiuri S, Roglic G, Hod M. Diagnosis of GDM: a suggested consensus. Best Pract Res Clin Obstet Gynaecol 2015;29(2):194-205.
  30. International Association of Diabetes and Pregnancy Study Groups Consensus Panel, Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010;33(3):676-82.
  31. Naylor CD, Sermer M, Chen E, Farine D. Selective screening for gestational dia- betes mellitus. Toronto Trihospital Gestational Diabetes Project Investigators. N Engl J Med 1997;337(22):1591-6.
  32. Neilsen KK, De Courten M, Kapur A. The urgent need for universally appli- cable simple screening procedures and diagnostic criteria for gestational diabetes mellitus -lessons from projects funded by the World Diabetes Foundation. Glob Health Action 2012;5:17277.
  33. Jiwani A, Marseille E, Lohse N, Damm P, Hod M, Kahn JG. Gestational diabetes mellitus: results from a survey of country prevalence and practices. J Matern Fetal Neonatal Med 2012;25(6):600-10.
  34. Moses RG, Cheung NW. Point: Universal screening for gestational diabetes mellitus. Diabetes Care 2009;32(7):1349-51.
  35. Simmons D, Moses RG. Gestational diabetes mellitus: to screen or not to screen?: Is this really still a question? Diabetes Care 2013;36(10):2877-8.
  36. Agarwal MM, Dhatt GS, Shah SM. Gestational diabetes mellitus: simplifying the international association of diabetes and pregnancy diagnostic algorithm using fasting plasma glucose. Diabetes Care 2010;33(9):2018-20.
  37. Zhu WW, Fan L, Yang HX, Kong LY, Su SP, Wang ZL, et al. Fasting plasma glu- cose at 24-28 weeks to screen for gestational diabetes mellitus: new evi- dence from China. Diabetes Care. 2013 Jul;36(7):2038-40.
  38. Anjalakshi C, Balaji V, Balaji MS, Ashalata S, Suganthi S, Arthi T, et al. A sin- gle test procedure to diagnose gestational diabetes mellitus. Acta Diabetol 2009;46(1):51-4.
  39. Seshiah V, Balaji V, Shah SN, Joshi S, Das AK, Sahay BK, et al. Diagnosis of gestational diabetes mellitus in the community. J Assoc Physicians India 2012;60:15-7.
  40. Qiao Q, Hu G, Tuomilehto J, Nakagami T, Balkau B, Borch-Johnsen K, et al. Age- and sex-specific prevalence of diabetes and impaired glucose regulation in 11 Asian cohorts. Diabetes Care 2003;26(6):1770-80.
  41. Ramachandran A, Ma RC, Snehalatha C. Diabetes in Asia. Lancet 2010;375(9712):408-18.
  42. Qiao Q, Nakagami T, Tuomilehto J, Borch-Johnsen K, Balkau B, Iwamoto Y, et al. Comparison of the fasting and the 2-h glucose criteria for diabetes in dif- ferent Asian cohorts. Diabetologia 2000;43(12):1470-5.
  43. Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, et al. Prevalence of diabetes among men and women in China. N Engl J Med 2010;362(12):1090-101.
  44. de Sereday MS, Damiano MM, González CD, Bennett PH. Diagnostic crite- ria for gestational diabetes in relation to pregnancy outcome. J Diabetes Complications 2003;17(3):115-9.
  45. Nielsen KK, Kapur A, Damm P, de Courten M, Bygbjerg IC. From screening to postpartum follow-up -the determinants and barriers for gestational diabe- tes mellitus (GDM) services, a systematic review. BMC Pregnancy Childbirth 2014;14:41.
  46. Zhu WW, Yang HX, Wei YM, Yan J, Wang ZL, Li XL, et al. Evaluation of the value of fasting plasma glucose in the first prenatal visit to diagnose gesta- tional diabetes mellitus in China. Diabetes Care 2013;36(3):586-90.
  47. Jensen DM, Mølsted-Pedersen L, Beck-Nielsen H, Westergaard JG, Ovesen P, Damm P. Screening for gestational diabetes mellitus by a model based on risk indicators: a prospective study. Am J Obstet Gynecol 2003;189(5):1383-8.
  48. Phaloprakarn C, Tangjitgamol S, Manusirivithaya S. A risk score for selective screening for gestational diabetes mellitus. Eur J Obstet Gynecol Reprod Biol 2009;145(1):71-5.
  49. Tran TS, Hirst JE, Do MA, Morris JM, Jeffery HE. Early prediction of gestational diabetes mellitus in Vietnam: clinical impact of currently recommended diagnostic criteria. Diabetes Care 2013;36(3):618-24.
  50. Poncet B, Touzet S, Rocher L, Berland M, Orgiazzi J, Colin C. Cost-effectiveness analysis of gestational diabetes mellitus screening in France. Eur J Obstet Gynecol Reprod Biol 2002;103(2):122-9.
  51. Marseille E, Lohse N, Jiwani A, Hod M, Seshiah V, Yajnik CS, et al . The cost- effectiveness of gestational diabetes screening including prevention of type 2 diabetes: application of a new model in India and Israel. J Matern Fetal Neonatal Med 2013;26(8):802-10.
  52. Sacks DB, Arnold M, Bakris GL, Bruns DE, Horvath AR, Kirkman MS, et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Diabetes Care 2011;34(6):e61-99.
  53. Polen M. AACC urges New York State to rescind policy directive that could nega- tively impact patients by restricting the use of blood glucose meters. American Association for Clinical Chemistry; June 17, 2014. https://www.aacc.org/media/ press-release-archive/2014/aacc-urges-new-york-state-to-rescind-policy-directive
  54. Schrot RJ, Patel KT, Foulis P. Evaluation of inaccuracies in the measurement of glycemia in the laboratory, by glucose meters, and through measurement of hemoglobin A1c. Clinical Diabetes 2007;25(2):43-49. References
  55. Committee on Practice Bulletins--Obstetrics. Practice Bulletin No. 137: Gestational diabetes mellitus. Obstet Gynecol 2013;122(2 Pt 1):406-16.
  56. Tita AT, Landon MB, Spong CY, Lai Y, Leveno KJ, Varner MW, et al. Timing of elective repeat cesarean delivery at term and neonatal outcomes. N Engl J Med 2009;360(2):111-20.
  57. Rosenstein MG, Cheng YW, Snowden JM, Nicholson JM, Doss AE, Caughey AB. The risk of stillbirth and infant death stratified by gestational age in women with gestational diabetes. Am J Obstet Gynecol 2012;206(4):309.e1-7.
  58. Kjos SL, Henry OA, Montoro M, Buchanan TA, Mestman JH. Insulin-requiring diabetes in pregnancy: a randomized trial of active induction of labor and expectant management. Am J Obstet Gynecol 1993;169(3):611-5.
  59. Rouse DJ, Owen J, Goldenberg RL, Cliver SP. The effectiveness and costs of elective cesarean delivery for fetal macrosomia diagnosed by ultrasound. JAMA 1996;276(18):1480-6.
  60. Nachum Z, Ben-Shlomo I, Weiner E, Shalev E. Twice daily versus four times daily insulin dose regimens for diabetes in pregnancy: randomised control- led trial. BMJ 1999;319(7219):1223-7.
  61. Yogev Y, Ben-Haroush A, Chen R, Glickman H, Kaplan B, Hod M. Active induc- tion management of labor for diabetic pregnancies at term; mode of delivery and fetal outcome--a single center experience. Eur J Obstet Gynecol Reprod Biol 2004;114(2):166-70.
  62. American College of Obstetricians and Gynecologists (College); Society for Maternal-Fetal Medicine, Caughey AB, Cahill AG, Guise JM, Rouse DJ. Safe prevention of the primary cesarean delivery. Am J Obstet Gynecol 2014;210(3):179-93.
  63. Jovanovic L, Savas H, Mehta M, Trujillo A, Pettitt DJ. Frequent monitoring of A1C during pregnancy as a treatment tool to guide therapy. Diabetes Care. 2011;34(1):53-4.
  64. Brustman L, Langer O, Engel S, Anyaegbunam A, Mazze R. Verified self-mon- itored blood glucose data versus glycosylated hemoglobin and glycosylated serum protein as a means of predicting short-and long-term metabolic con- trol in gestational diabetes. Am J Obstet Gynecol 1987;157(3):699-703.
  65. Hawkins JS, Casey BM, Lo JY, Moss K, McIntire DD, Leveno KJ. Weekly com- pared with daily blood glucose monitoring in women with diet-treated ges- tational diabetes. Obstet Gynecol 2009;113(6):1307-12.
  66. Jovanovic LG. Using meal-based self-monitoring of blood glucose as a tool to improve outcomes in pregnancy complicated by diabetes. Endocr Pract 2008;14(2):239-47.
  67. Cheng YW, Caughey AB. Gestational diabetes: diagnosis and management. J Perinatol 2008;28(10):657-64.
  68. Wilson N, Ashawesh K, Kulambil Padinjakara RN, Anwar A. The multidisci- plinary diabetes-endocrinology clinic and postprandial blood glucose moni- toring in the management of gestational diabetes: impact on maternal and neonatal outcomes. Exp Clin Endocrinol Diabetes 2009;117(9):486-9.
  69. Yogev Y, Ben-Haroush A, Chen R, Kaplan B, Phillip M, Hod M. Continuous glu- cose monitoring for treatment adjustment in diabetic pregnancies--a pilot study. Diabet Med 2003;20(7):558-62.
  70. Garg S, Zisser H, Schwartz S, Bailey T, Kaplan R, Ellis S, et al. Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial. Diabetes Care 2006;29(1):44-50.
  71. Kestilä KK, Ekblad UU, Rönnemaa T. Continuous glucose monitoring versus self-monitoring of blood glucose in the treatment of gestational diabetes mellitus. Diabetes Res Clin Pract 2007;77(2):174-9.
  72. JDRF CGM Study Group. JDRF randomized clinical trial to assess the effi- cacy of real-time continuous glucose monitoring in the management of type 1 diabetes: research design and methods. Diabetes Technol Ther 2008;10(4):310-21.
  73. Deiss D, Bolinder J, Riveline JP, Battelino T, Bosi E, Tubiana-Rufi N, et al. Improved glycemic control in poorly controlled patients with type 1 dia- betes using real-time continuous glucose monitoring. Diabetes Care 2006;29(12):2730-2.
  74. McLachlan K, Jenkins A, O'Neal D. The role of continuous glucose monitor- ing in clinical decision-making in diabetes in pregnancy. Aust N Z J Obstet Gynaecol 2007;47(3):186-90.
  75. Secher AL, Ringholm L, Andersen HU, Damm P, Mathiesen ER. The effect of real-time continuous glucose monitoring in pregnant women with diabetes: a randomized controlled trial. Diabetes Care 2013;36(7):1877-83.
  76. Langer O, Levy J, Brustman L, Anyaegbunam A, Merkatz R, Divon M. Glycemic control in gestational diabetes mellitus--how tight is tight enough: small for gestational age versus large for gestational age? Am J Obstet Gynecol 1989;161(3):646-53.
  77. Walker JD. NICE guidance on diabetes in pregnancy: management of diabetes and its complications from preconception to the postnatal period. NICE clini- cal guideline 63. London, March 2008. Diabet Med 2008;25(9):1025-7.
  78. de Veciana M, Major CA, Morgan MA, Asrat T, Toohey JS, Lien JM, et al. Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. N Engl J Med 1995;333(19):1237-41.
  79. HAPO Study Cooperative Research Group. The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. Int J Gynecol Obstet 2002;78(1):69-77.
  80. Pedersen J. Weight and length at birth of infants of diabetic mothers. Acta Endocrinol (Copenh) 1954;16(4):330-42.
  81. Balsells M, Corcoy R, Adelantado JM, García-Patterson A, Altirriba O, de Leiva A. Gestational diabetes mellitus: metabolic control during labour. Diabetes Nutr Metab 2000;13(5):257-62.
  82. Andersen O, Hertel J, Schmølker L, Kühl C. Influence of the maternal plasma glucose concentration at delivery on the risk of hypoglycaemia in infants of insulin-dependent diabetic mothers. Acta Paediatr Scand 1985;74(2):268-73.
  83. Curet LB, Izquierdo LA, Gilson GJ, Schneider JM, Perelman R, Converse J. Relative effects of antepartum and intrapartum maternal blood glucose lev- els on incidence of neonatal hypoglycemia. J Perinatol 1997;17(2):113-5.
  84. Lean ME, Pearson DW, Sutherland HW. Insulin management during labour and delivery in mothers with diabetes. Diabet Med 1990;7(2):162-4.
  85. Feldberg D, Dicker D, Samuel N, Peleg D, Karp M, Goldman JA. Intrapartum management of insulin-dependent diabetes mellitus (IDDM) gestants. A comparative study of constant intravenous insulin infusion and continu- ous subcutaneous insulin infusion pump (CSIIP). Acta Obstet Gynecol Scand 1988;67(4):333-8.
  86. Carron Brown S, Kyne-Grzebalski D, Mwangi B, Taylor R. Effect of manage- ment policy upon 120 Type 1 diabetic pregnancies: policy decisions in prac- tice. Diabet Med 1999;16(7):573-8.
  87. Gunderson EP, Abrams B. Epidemiology of gestational weight gain and body weight changes after pregnancy. Epidemiol Rev 2000;22(2):261-74.
  88. Institute of Medicine. Weight Gain During Pregnancy: Reexamining the Guidelines. Washington (DC): National Academies Press (US); 2009.
  89. Artal R, Catanzaro RB, Gavard JA, Mostello DJ, Friganza JC. A lifestyle inter- vention of weight-gain restriction: diet and exercise in obese women with gestational diabetes mellitus. Appl Physiol Nutr Metab 2007;32(3):596-601.
  90. Catalano PM, Mele L, Landon MB, Ramin SM, Reddy UM, Casey B, et al. Inadequate weight gain in overweight and obese pregnant women: what is the effect on fetal growth? Am J Obstet Gynecol 2014;211(2):137.e1-7.
  91. American Diabetes Association Workshop-Conference on gestational diabe- tes: summary and recommendations. Diabetes Care 1980;3(3):499-501.
  92. Freinkel N. Summary and recommendations of the Second International Workshop-Conference on Gestational Diabetes. Diabetes 1985;34(Suppl 2):S123-S126.
  93. Proceedings of the 4th International Workshop-Conference on Gestational Diabetes Mellitus. Chicago, Illinois, USA. 14-16 March 1997. Diabetes Care 1998;21(Suppl 2):B1-167.
  94. Gunderson EP. Gestational diabetes and nutritional recommendations. Curr Diab Rep 2004;4(5):377-86.
  95. Kulkarni K, Castle G, Gregory R, Holmes A, Leontos C, Powers M, et al. Nutrition Practice Guidelines for Type 1 Diabetes Mellitus positively affect dietitian practices and patient outcomes. The Diabetes Care and Education Dietetic Practice Group. J Am Diet Assoc 1998;98(1):6270.
  96. Reader D, Splett P, Gunderson EP, Diabetes Care and Education Dietetic Practice Group. Impact of gestational diabetes mellitus nutrition practice guidelines implemented by registered dietitians on pregnancy outcomes. J Am Diet Assoc 2006;106(9):1426-33.
  97. Knopp RH, Magee MS, Raisys V, Benedetti T, Bonet B. Hypocaloric diets and ketogenesis in the management of obese gestational diabetic women. J Am Coll Nutr 1991;10(6):649-67.
  98. Algert S, Shragg P, Hollingsworth DR. Moderate caloric restriction in obese women with gestational diabetes. Obstet Gynecol 1985;65(4):487-91.
  99. Rae A, Bond D, Evans S, North F, Roberman B, Walters B. A randomised con- trolled trial of dietary energy restriction in the management of obese women with gestational diabetes. Aust N Z J Obstet Gynaecol 2000;40(4):416-22.
  100. Rizzo T, Metzger BE, Burns WJ, Burns K. Correlations between antepartum maternal metabolism and child intelligence. N Engl J Med 1991;325(13):911-6.
  101. Foyett JP. Management of obesity. Prim Care Rep 2000;6:19.
  102. Snyder J, Gray-Donald K, Koski KG. Predictors of infant birth weight in gesta- tional diabetes. Am J Clin Nutr 1994;59(6):1409-14.
  103. Institute of Medicine. Dietary Reference Intakes: Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids. Washington, DC: National Academies Press; 2002.
  104. Brand-Miller J, Hayne S, Petocz P, Colagiuri S. Low-glycemic index diets in the management of diabetes: a meta-analysis of randomized controlled trials. Diabetes Care 2003;26(8):2261-7.
  105. Clapp JF. Diet, exercise, and feto-placental growth. Arch Gynecol Obstet 1997;261:101-107.
  106. Scholl TO, Chen X, Khoo CS, Lenders C. The dietary glycemic index during pregnancy: influence on infant birth weight, fetal growth, and biomarkers of carbohydrate metabolism. Am J Epidemiol 2004;159(5):467-74.
  107. Lock DR, Bar-Eyal A, Voet H, Madar Z. Glycemic indices of various foods given to pregnant diabetic subjects. Obstet Gynecol 1988;71(2):180-3.
  108. Institute of Medicine. Dietary Reference Intakes: Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids. Washington, DC: National Academies Press; 2002:389.
  109. Avery MD, Walker AJ. Acute effect of exercise on blood glucose and insulin lev- els in women with gestational diabetes. J Matern Fetal Med 2001;10(1):52-8.
  110. Russo LM, Nobles C, Ertel KA, Chasan-Taber L, Whitcomb BW. Physical activ- ity interventions in pregnancy and risk of gestational diabetes mellitus: a systematic review and meta-analysis. Obstet Gynecol 2015;125(3):576-82.
  111. Ratner RE, Christophi CA, Metzger BE, Dabelea D, Bennett PH, Pi-Sunyer X, et al. Prevention of diabetes in women with a history of gestational diabe- tes: effects of metformin and lifestyle interventions. J Clin Endocrinol Metab 2008;93(12):4774-9.
  112. Bao W, Tobias DK, Bowers K, Chavarro J, Vaag A, Grunnet LG, et al. Physical activity and sedentary behaviors associated with risk of progression from gestational diabetes mellitus to type 2 diabetes mellitus: a prospective cohort study. JAMA Intern Med 2014;174(7):1047-55.
  113. ACOG technical bulletin. Diabetes and pregnancy. No. 200-December 1994 (replaces No. 92, May 1986). Committee on Technical Bulletins of the American College of Obstetricians and Gynecologists. Int J Gynecol Obstet 1995;48(3):331-9.
  114. Metzger BE, Coustan DR. Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. The Organizing Committee. Diabetes Care 1998;21(Suppl 2):B161-7.
  115. Zucker P, Simon G. Prolonged symptomatic neonatal hypoglycemia associ- ated with maternal chlorpropamide therapy. Pediatrics 1968;42(5):824-5.
  116. Farquhar JW, Isles TE. Hypoglycemia in newborn infants of normal and dia- betic mothers. S Afr Med J 1968;42(10):237-45.
  117. Kemball ML, McIver C, Milner RD, Nourse CH, Schiff D, Tiernan JR. Neonatal hypoglycaemia in infants of diabetic mothers given sulphonylurea drugs in pregnancy. Arch Dis Child 1970;45(243):696-701.
  118. Smoak IW, Sadler TW. Embryopathic effects of short-term expo- sure to hypoglycemia in mouse embryos in vitro. Am J Obstet Gynecol 1990;163(2):619-24.
  119. Denno KM, Sadler TW. Effects of the biguanide class of oral hypoglycemic agents on mouse embryogenesis. Teratology 1994;49(4):260-6.
  120. Sutherland HW, Stowers JM, Cormack JD, Bewsher PD. Evaluation of chlo- rpropamide in chemical diabetes diagnosed during pregnancy. Br Med J 1973;3(5870):9-13.
  121. Sutherland HW, Bewsher PD, Cormack JD, Hughes CR, Reid A, Russell G, et al. Effect of moderate dosage of chlorpropamide in pregnancy on fetal outcome. Arch Dis Child 1974;49(4):283-91.
  122. Notelovitz M. Letter: Oral hypoglycaemic therapy in diabetic pregnancies. Lancet 1974;2(7885):902-3.
  123. Coetzee EJ, Jackson WP. Oral hypoglycaemics in the first trimester and fetal outcome. S Afr Med J 1984;65(16):635-7.
  124. Piacquadio K, Hollingsworth DR, Murphy H. Effects of in-utero exposure to oral hypoglycaemic drugs. Lancet 1991;338(8771):866-9.
  125. Metzger BE, Buchanan TA, Coustan DR, de Leiva A, Dunger DB, Hadden DR, et al. Summary and recommendations of the Fifth International Workshop- Conference on Gestational Diabetes Mellitus. Diabetes Care 2007;30(Suppl 2):S251-60.
  126. National Collaborating Centre for Women's and Children's Health (UK). Diabetes in Pregnancy: Management of Diabetes and Its Complications from Preconception to the Postnatal Period. (NICE Clinical Guideline, No.63). London: RCOG Press; 2008.
  127. Hunt KJ, Schuller KL. The increasing prevalence of diabetes in pregnancy. Obstet Gynecol Clin North Am 2007;34(2):173-99.
  128. Elliott BD, Schenker S, Langer O, Johnson R, Prihoda T. Comparative placental transport of oral hypoglycemic agents in humans: a model of human placen- tal drug transfer. Am J Obstet Gynecol 1994;171(3):653-60.
  129. Langer O, Conway DL, Berkus MD, Xenakis EM, Gonzales O. A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med 2000;343(16):1134-8.
  130. Kraemer J, Klein J, Lubetsky A, Koren G. Perfusion studies of glyburide trans- fer across the human placenta: implications for fetal safety. Am J Obstet Gynecol 2006;195(1):270-4.
  131. Nanovskaya TN, Patrikeeva S, Hemauer S, Fokina V, Mattison D, Hankins GD, et al. Effect of albumin on transplacental transfer and distribution of rosigli- tazone and glyburide. J Matern Fetal Neonatal Med 2008;21(3):197-207.
  132. Kremer CJ, Duff P. Glyburide for the treatment of gestational diabetes. Am J Obstet Gynecol 2004;190(5):1438-9.
  133. Jacobson GF, Ramos GA, Ching JY, Kirby RS, Ferrara A, Field DR. Comparison of glyburide and insulin for the management of gestational diabetes in a large managed care organization. Am J Obstet Gynecol 2005;193(1):118-24.
  134. Ramos GA, Jacobson GF, Kirby RS, Ching JY, Field DR. Comparison of glybu- ride and insulin for the management of gestational diabetics with markedly elevated oral glucose challenge test and fasting hyperglycemia. J Perinatol 2007;27(5):262-7.
  135. Lain KY, Garabedian MJ, Daftary A, Jeyabalan A. Neonatal adiposity following maternal treatment of gestational diabetes with glyburide compared with insulin. Am J Obstet Gynecol 2009;200(5):501.e1-6.
  136. Charles B, Norris R, Xiao X, Hague W. Population pharmacokinetics of met- formin in late pregnancy. Ther Drug Monit 2006;28(1):67-72.
  137. Eyal S, Easterling TR, Carr D, Umans JG, Miodovnik M, Hankins GD, et al. Pharmacokinetics of metformin during pregnancy. Drug Metab Dispos 2010;38(5):833-40.
  138. Gargaun S, Ryan E, Greenblatt E, Fettes I, Shapiro H, Padjen A, et al. Pregnancy outcome in women with polycystic ovary syndrome exposed to metformin. Can J Clin Pharmacol 2003;10(3):e149.
  139. Zhuo Z, Wang A, Yu H. Effect of metformin intervention during pregnancy on the gestational diabetes mellitus in women with polycystic ovary syndrome: a systematic review and meta-analysis. J Diabetes Res 2014;2014:381231.
  140. Carlsen SM, Martinussen MP, Vanky E. Metformin's effect on first-year weight gain: a follow-up study. Pediatrics 2012;130(5):e1222-6.
  141. Rø TB, Ludvigsen HV, Carlsen SM, Vanky E. Growth, body composition and metabolic profile of 8-year-old children exposed to metformin in utero. Scand J Clin Lab Invest 2012;72(7):570-5.
  142. Li G, Zhao S, Cui S, Li L, Xu Y, Li Y. Effect comparison of metformin with insu- lin treatment for gestational diabetes: a meta-analysis based on RCTs. Arch Gynecol Obstet 2015;292(1):111-20.
  143. Glueck CJ, Wang P. Metformin before and during pregnancy and lactation in polycystic ovary syndrome. Expert Opin Drug Saf 2007;6(2):191-8.
  144. Moore LE, Clokey D, Rappaport VJ, Curet LB. Metformin compared with gly- buride in gestational diabetes: a randomized controlled trial. Obstet Gynecol 2010;115(1):55-9.
  145. Silva JC, Pacheco C, Bizato J, de Souza BV, Ribeiro TE, Bertini AM. Metformin compared with glyburide for the management of gestational diabetes. Int J Gynecol Obstet 2010;111(1):37-40.
  146. Conway DL, Gonzales O, Skiver D. Use of glyburide for the treatment of ges- tational diabetes: the San Antonio experience. J Matern Fetal Neonatal Med 2004;15(1):51-5.
  147. Gui J, Liu Q, Feng L. Metformin vs insulin in the management of gestational diabetes: a meta-analysis. PLoS One 2013;8(5):e64585.
  148. Pertot T, Molyneaux L, Tan K, Ross GP, Yue DK, Wong J. Can common clinical parameters be used to identify patients who will need insulin treatment in gestational diabetes mellitus? Diabetes Care 2011;34(10):2214-6.
  149. Di Cianni G, Torlone E, Lencioni C, Bonomo M, Di Benedetto A, Napoli A, et al. Perinatal outcomes associated with the use of glargine during pregnancy. Diabet Med 2008;25(8):993-6.
  150. Langer O, Anyaegbunam A, Brustman L, Guidetti D, Levy J, Mazze R. Pregestational diabetes: insulin requirements throughout pregnancy. Am J Obstet Gynecol 1988;159(3):616-21.
  151. Borgoño CA, Zinman B. Insulins: past, present, and future. Endocrinol Metab Clin North Am 2012;41(1):1-24.
  152. Boskovic R, Feig DS, Derewlany L, Knie B, Portnoi G, Koren G. Transfer of insu- lin lispro across the human placenta: in vitro perfusion studies. Diabetes Care 2003;26(5):1390-4.
  153. Holcberg G, Tsadkin-Tamir M, Sapir O, Wiznizer A, Segal D, Polachek H, et al. Transfer of insulin lispro across the human placenta. Eur J Obstet Gynecol Reprod Biol 2004;115(1):117-8.
  154. Jovanovic L, Ilic S, Pettitt DJ, Hugo K, Gutierrez M, Bowsher RR, et al. Metabolic and immunologic effects of insulin lispro in gestational diabetes. Diabetes Care 1999;22(9):1422-7.
  155. Wyatt JW, Frias JL, Hoyme HE, Jovanovic L, Kaaja R, Brown F, et al. Congenital anomaly rate in offspring of mothers with diabetes treated with insulin lis- pro during pregnancy. Diabet Med 2005;22(6):803-7.
  156. Bhattacharyya A, Vice PA. Insulin lispro, pregnancy, and retinopathy. Diabetes Care 1999;22(12):2101-4.
  157. Buchbinder A, Miodovnik M, McElvy S, Rosenn B, Kranias G, Khoury J, et al. Is insulin lispro associated with the development or progression of diabetic retinopathy during pregnancy? Am J Obstet Gynecol 2000;183(5):1162-5.
  158. Loukovaara S, Immonen I, Teramo KA, Kaaja R. Progression of retinopathy during pregnancy in type 1 diabetic women treated with insulin lispro. Diabetes Care 2003;26(4):1193-8.
  159. Bhattacharyya A, Brown S, Hughes S, Vice PA. Insulin lispro and regular insu- lin in pregnancy. QJM 2001;94(5):255-60.
  160. Lapolla A, Dalfrà MG, Spezia R, Anichini R, Bonomo M, Bruttomesso D, et al. Outcome of pregnancy in type 1 diabetic patients treated with insulin lispro or regular insulin: an Italian experience. Acta Diabetol 2008;45(1):61-6.
  161. Durnwald CP, Landon MB. A comparison of lispro and regular insulin for the management of type 1 and type 2 diabetes in pregnancy. J Matern Fetal Neonatal Med 2008;21(5):309-13.
  162. Pettitt DJ, Ospina P, Kolaczynski JW, Jovanovic L. Comparison of an insulin analog, insulin aspart, and regular human insulin with no insulin in gesta- tional diabetes mellitus. Diabetes Care 2003;26(1):183-6.
  163. Hod M, Damm P, Kaaja R, Visser GH, Dunne F, Demidova I, et al. Fetal and perinatal outcomes in type 1 diabetes pregnancy: a randomized study comparing insulin aspart with human insulin in 322 subjects. Am J Obstet Gynecol 2008;198(2):186.e1-7.
  164. McCance DR, Damm P, Mathiesen ER, Hod M, Kaaja R, Dunne F, et al. Evaluation of insulin antibodies and placental transfer of insulin aspart in pregnant women with type 1 diabetes mellitus. Diabetologia 2008;51(11):2141-3.
  165. Lapolla A, Di Cianni G, Bruttomesso D, Dalfrà MG, Fresa R, Mello G, et al. Use of insulin detemir in pregnancy: a report on 10 Type 1 diabetic women. Diabet Med 2009;26(11):1181-2.
  166. Bartley PC, Bogoev M, Larsen J, Philotheou A. Long-term efficacy and safety of insulin detemir compared to Neutral Protamine Hagedorn insulin in patients with Type 1 diabetes using a treat-to-target basal-bolus regimen with insulin aspart at meals: a 2-year, randomized, controlled trial. Diabet Med 2008;25(4):442-9.
  167. Russell-Jones D, Simpson R, Hylleberg B, Draeger E, Bolinder J. Effects of QD insulin detemir or neutral protamine Hagedorn on blood glucose control in patients with type I diabetes mellitus using a basal-bolus regimen. Clin Ther 2004;26(5):724-36.
  168. Mathiesen ER, Hod M, Ivanisevic M, Duran Garcia S, Brøndsted L, Jovanovic L, et al. Maternal efficacy and safety outcomes in a randomized, controlled trial comparing insulin detemir with NPH insulin in 310 pregnant women with type 1 diabetes. Diabetes Care 2012;35(10):2012-7.
  169. Hod M, Mathiesen ER, Jovanovic L, McCance DR, Ivanisevic M, Durán-Garcia S, et al. A randomized trial comparing perinatal outcomes using insulin detemir or neutral protamine Hagedorn in type 1 diabetes. J Matern Fetal Neonatal Med 2014;27(1):7-13.
  170. Callesen NF, Damm J, Mathiesen JM, Ringholm L, Damm P, Mathiesen ER. Treatment with the long-acting insulin analogues detemir or glargine during pregnancy in women with type 1 diabetes: comparison of glycaemic control and pregnancy outcome. J Matern Fetal Neonatal Med 2013;26(6):588-92.
  171. Lepercq J, Lin J, Hall GC, Wang E, Dain MP, Riddle MC, et al. Meta-analysis of maternal and neonatal outcomes associated with the use of insulin glargine versus NPH insulin during pregnancy. Obstet Gynecol Int 2012;2012:649070.
  172. Pollex E, Moretti ME, Koren G, Feig DS. Safety of insulin glargine use in pregnancy: a systematic review and meta-analysis. Ann Pharmacother 2011;45(1):9-16.
  173. Linder N, Lahat Y, Kogan A, Fridman E, Kouadio F, Melamed N, et al. Macrosomic newborns of non-diabetic mothers: anthropometric measurements and neo- natal complications. Arch Dis Child Fetal Neonatal Ed 2014;99(5):F353-8.
  174. Mayer-Davis EJ, Rifas-Shiman SL, Zhou L, Hu FB, Colditz GA, Gillman MW. Breast-feeding and risk for childhood obesity: does maternal diabetes or obesity status matter? Diabetes Care 2006;29(10):2231-7.
  175. O'Reilly M, Avalos G, Dennedy MC, O'Sullivan EP, Dunne FP. Breast-feeding is associated with reduced postpartum maternal glucose intolerance after gestational diabetes. Ir Med J 2012;105(5 Suppl):31-6.
  176. Owen CG, Martin RM, Whincup PH, Smith GD, Cook DG. Does breastfeed- ing influence risk of type 2 diabetes in later life? A quantitative analysis of published evidence. Am J Clin Nutr 2006;84(5):1043-54.
  177. Plagemann A, Harder T, Franke K, Kohlhoff R. Long-term impact of neonatal breast-feeding on body weight and glucose tolerance in children of diabetic mothers. Diabetes Care 2002;25(1):16-22.
  178. Skouby SO, Mølsted-Pedersen L, Petersen KR. Contraception for women with diabetes: an update. Baillieres Clin Obstet Gynaecol 1991;5(2):493-503.
  179. Beydoun HA, Beydoun MA, Tamim H. How does gestational diabetes affect postpartum contraception in nondiabetic primiparous women? Contraception 2009;79(4):290-6.
  180. Metzger BE, Buchanan TA, Coustan DR, de Leiva A, Dunger DB, Hadden DR, et al. Summary and recommendations of the Fifth International Workshop- Conference on Gestational Diabetes Mellitus. Diabetes Care 2007;30(Suppl 2):S251-60.
  181. Ratner RE, Christophi CA, Metzger BE, Dabelea D, Bennett PH, Pi-Sunyer X, et al. Prevention of diabetes in women with a history of gestational diabe- tes: effects of metformin and lifestyle interventions. J Clin Endocrinol Metab 2008;93(12):4774-9.
  182. Aroda VR, Christophi CA, Edelstein SL, Zhang P, Herman WH, Barrett-Connor E, et al The effect of lifestyle intervention and metformin on preventing or delaying diabetes among women with and without gestational diabetes: the diabetes prevention program outcomes study 10-year follow-up. J Clin Endocrinol Metab 2015;100(4):1646-53.
  183. Bao W, Tobias DK, Bowers K, Chavarro J, Vaag A, Grunnet LG, et al. Physical activity and sedentary behaviors associated with risk of progression from gestational diabetes mellitus to type 2 diabetes mellitus: a prospective cohort study. JAMA Intern Med 2014;174(7):1047-55.
  184. Nielsen KK, Kapur A, Damm P, de Courten M, Bygbjerg IC. From screening to postpartum follow-up -the determinants and barriers for gestational diabe- tes mellitus (GDM) services, a systematic review. BMC Pregnancy Childbirth 2014;14:41.
  185. Cox M, Whittle MJ, Byrne A, Kingdom JC, Ryan G. Prepregnancy counselling: experience from 1,075 cases. Br J Obstet Gynaecol 1992;99(11):873-6.
  186. American College of Obstetricians and Gynecologists. ACOG Committee Opinion number 313, September 2005. The importance of preconcep- tion care in the continuum of women's health care. Obstet Gynecol 2005;106(3):665-6.
  187. American College of Obstetricians and Gynecologists. Guidelines for wom- en's health care. Second Edition. Washington, DC: American College of Obstetricians and Gynecologists; 1996.
  188. American Academy of Pediatrics, American College of Obstetricians and Gynecologists. Guidelines for perinatal care. Fifth Edition. Elk Grove Village, IL: American Academy of Pediatrics; 2002. Washington, DC: American College of Obstetricians and Gynecologists; 2002.
  189. Adams MM, Bruce FC, Shulman HB, Kendrick JS, Brogan DJ. Pregnancy plan- ning and pre-conception counseling. The PRAMS Working Group. Obstet Gynecol 1993;82(6):955-9.
  190. Kim C, Ferrara A, McEwen LN, Marrero DG, Gerzoff RB, Herman WH, et al. Preconception care in managed care: the translating research into action for diabetes study. Am J Obstet Gynecol 2005;192(1):227-32.
  191. Jack BW, Culpepper L. Preconception care. J Fam Pract 1991;32(3):306-15.
  192. Frey KA. Preconception care by the nonobstetrical provider. Mayo Clin Proc 2002;77(5):469-73.
  193. Moos MK. Preconceptional health promotion: opportunities abound. Matern Child Health J 2002;6(2):71-3.
  194. Moos MK. Preconceptional wellness as a routine objective for women's health care: an integrative strategy. J Obstet Gynecol Neonatal Nurs 2003;32(4):550-6.
  195. Reece EA, Homko CJ. Prepregnancy care and the prevention of fetal mal- formations in the pregnancy complicated by diabetes. Clin Obstet Gynecol 2007;50(4):990-7.
  196. Hader E, Ashwal E, Hod M. The preconceptional period as an opportunity for prediction and prevention of noncommunicable disease. Best Pract Res Clin Obstet Gynaecol 2015;29(1):54-62.
  197. Seshiah V, Balaji V, Shah SN, Joshi S, Das AK, Sahay BK, et al. Diagnosis of gestational diabetes mellitus in the community. J Assoc Physicians India 2012;60:15-7.
  198. Seshiah V, Balaji V, Balaji MS, Sanjeevi CB, Green A. Gestational diabetes mel- litus in India. J Assoc Physicians India 2004;52:707-11.
  199. Divakar H, Manyonda IT. Battling the rising prevalence of gestational diabe- tes in India: Are clinicians on the right track? Journal of Neonatal-Perinatal Medicine 2012;5(3).
  200. International Association of Diabetes and Pregnancy Study Groups Consensus Panel, Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010;33(3):676-82.

200 of 214 shown

Cited by

Sorted by citations

Authors
Hod, M., Kapur, A., Sacks, D. A., Hadar, E., Agarwal, M., Di Renzo, G. C., Roura, L. C., McIntyre, H. D., Morris, J. L., & Divakar, H.
Affiliations
  • Tel Aviv University (IL)
  • World Diabetes Foundation (DK)
  • Kaiser Permanente (US)
  • United Arab Emirates University (AE)
  • International Federation of Gynaecology and Obstetrics (GB)
Corresponding author
Morris, Jessica L.
ORCID
Venue
International Journal of Gynecology & Obstetrics
Publisher
Wiley
Published
2015-10
Volume
131
Issue
S3
Pages
S173-211
ISSN
  • 0020-6695 (ISSN-L)
  • 0020-7292
  • 1879-3479
DOI
10.1016/s0020-7292(15)30033-3
OpenAlex
W2169476389
Cited by
767
References
33
Citations by year
2026: 23 · 2025: 37 · 2024: 73 · 2023: 91 · 2022: 98 · 2021: 108 · 2020: 109 · 2019: 81 · 2018: 72 · 2017: 46 · 2016: 28 · 2014: 1
FWCI
55.38
Type
journal article
Language
en
Open access
Licence
Locations
  • International Journal of Gynecology & Obstetrics (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • INFM-OAR (INFN Catania) (submittedVersion, other-oa)
Funders
Novo Nordisk
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
Keywords
gestational diabetes mellitus, diagnosis, management, care, diabetes in pregnancy, FIGO guidelines, international consensus
MeSH terms
Female, Gynecology, Humans, Hyperglycemia, International Agencies, Obstetrics, Organizations, Nonprofit, Pregnancy, Pregnancy Complications, Risk Factors, Diabetes, Gestational

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review